Product Design & Development

Icagen gets 180 days to regain Nasdaq compliance

By The Associated Press
Friday, November 13, 2009
 Share
[-] Text [+]  
Loading...

Icagen gets 180 days to regain Nasdaq compliance

RESEARCH TRIANGLE PARK, N.C., (AP) — Biopharmaceutical company Icagen Inc. said Friday the Nasdaq Stock Market has given the company 180 calendar days to regain compliance with its minimum listing requirements.

The company said its stock has closed below $1 per share for the past 30 business days. To regain compliance, the company's common stock must close at or above $1 per share for at least 10 business days before May 11, 2010.

Company shares rose 3 cents, or 6.7 percent, to close at 48 cents on Friday.

ADVERTISEMENT

JOIN THE DISCUSSION
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

At Issue

Beta Products & The Human Guinea Pig
Mike Willshaw, Radius Creative
My Garbage Blanket
Anna Wells, Editor, IMPO
A Quick Fix
Meaghan Ziemba, Associate Editor, PD&D

Quick Links

Site Sponsors


Most Viewed

Videos & Webcasts

Cannon vs. Skull 3/17/2010
Schmit Prototypes builds a canon powerful enough to blow your brains out.   Continue
Dynamic Structures Digital Prototyping 3/17/2010
When designing their structures, Dynamic Structures uses Audtodesk Inventor to go beyond 3D design.   Continue
Augmenting Reality 3/17/2010
The new technology makes driving more safe and convenient by enhancing the driver’s site.   Continue